Results 111 to 120 of about 50,656 (201)

Beyond Diabetes: A Review of Emerging Indications for Glucagon-Like Peptide-1 Receptor Agonists. [PDF]

Rev Cardiovasc Med
West L, Patolia H, Chapman B, Laffin L, Vest AR, Sauer AJ, Martyn T.   +6 more
europepmc   +1 more source

The Benefits and Risks of Glucagon-Like Peptide-1 Receptor Agonists on Ocular Diseases: A Narrative Review. [PDF]

Cureus
Huang JXF, Wu J, Ahmad H, Li J, Joshi S, Yousaf A, Pemminati R, Pemminati S.   +7 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists in Chronic Kidney Disease: Mechanisms and Clinical Perspectives. [PDF]

Kidney Med
Meier M, Cummings J, Abdelsaid M, Feliciano J, Eusebe J, Stirn H, Coucha M.   +6 more
europepmc   +1 more source

Glucagon-like peptide 1 receptor agonists in substance use disorders: A systematic review of ClinicalTrials.Gov. [PDF]

Addict Behav Rep
Patil S, Jha N, Jha MK.
europepmc   +1 more source

Glucagon-Like Peptide 1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases. [PDF]

Arthritis Rheumatol
Karacabeyli D, Lacaille D, Lu N, Xie H, Aviña-Zubieta JA.   +4 more
europepmc   +1 more source

The Influence of Glucagon-like Peptide-1 Receptor Agonists on Outcomes Following Trigger Finger Release. [PDF]

J Hand Surg Glob Online
Dameron LS, Bank NC, Raghava N, Himmelberg S, Knoll GM.   +4 more
europepmc   +1 more source

Adverse events administering glucagon-like peptide-1 receptor agonists: a cross-sectional study. [PDF]

Health Aff Sch
Mattingly TJ, Duru EE, Conti RM.
europepmc   +1 more source

Impact of Glucagon-Like Peptide-1 Receptor Agonists on Knee Arthroplasty Outcomes. [PDF]

Indian J Orthop
Zaffar H, Imran MA, Rushd F.
europepmc   +1 more source

State‐Level Variation in Glucagon‐Like Peptide‐1 Receptor Agonists Fills and Spending by Obesity Prevalence, 2023

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Tamkeen Khan, Stavros Tsipas, Fleetwood Loustalot, Lindsay Zasadzinski, Klodiana Myftari, Alyson B. Goodman, Gregory D. Wozniak   +6 more
doaj   +1 more source

Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon-Like Peptide 1 Receptor Agonists. [PDF]

OTO Open
Sciscent BY, Eberly HW, Lorenz FJ, Goldrich D, Goyal N, Goldenberg D.   +5 more
europepmc   +1 more source